Valsartan oral solution — United Healthcare
Patients unable to ingest solid dosage forms requiring valsartan therapy
Preferred products
- enalapril oral solution
- Qbrelis
Initial criteria
- Patient is unable to ingest a solid dosage form (e.g. an oral tablet or capsule) due to age OR oral/motor difficulties OR dysphagia OR utilizes a feeding tube for medication administration
- AND Patient has a history of trial and failure, intolerance or contraindication to ONE of the following: enalapril oral solution (generic Epaned) OR Qbrelis (lisinopril) oral solution
Approval duration
12 months